Aberrant O-glycosylation of IgA1 and complement in IgA nephropathy: Glomerular immunodeposits of patients with histologically active disease exhibit elevated colocalization of IgA and complement C3

被引:0
|
作者
Novak, Lea [1 ,2 ]
Hall, Stacy D. [1 ,2 ]
Gurganus, Graham L. [1 ,2 ]
Rizk, Dana V. [1 ,2 ]
Julian, Bruce A. [1 ,2 ]
Haas, Mark [3 ]
Novak, Jan [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA
[3] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P105
引用
收藏
页码:1002 / 1003
页数:2
相关论文
共 50 条
  • [21] The genetic susceptibility to IgA nephropathy:: A novel functional candidate gene for incomplete O-glycosylation of IgA1
    Narita, I.
    Kaneko, Y.
    Kondo, D.
    Goto, S.
    Sakatsume, M.
    Gejyo, F.
    KIDNEY INTERNATIONAL, 2007, 71 (05) : 379 - 381
  • [22] Complement C3 and hyaline vascular deposits in IgA nephropathy
    Gherghiceanu, Mihaela
    Mandache, Eugen
    Ismail, Gener
    Voicilescu, Mihai
    Dumitrache, Sergiu
    VIRCHOWS ARCHIV, 2007, 451 (02) : 519 - 519
  • [23] Immune Complexes in the Peripheral Blood of Patients with IgA Nephropathy Contain Polymeric Galactose-Deficient IgA1 Associated with IgG and Complement C3
    Hall, Stacy D.
    Coffee, Sarah
    Maillard, Nicolas
    Moldoveanu, Zina
    Craine, Ellenore P.
    Hargett, Audra A.
    Rizk, Dana
    Julian, Bruce A.
    Renfrow, Matthew B.
    Novak, Jan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 457 - 457
  • [24] Activation of the acute phase response and complement C3 in patients with IgA nephropathy
    Janssen, U
    Bahlmann, F
    Köhl, J
    Zwirner, J
    Haubitz, M
    Floege, J
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (01) : 21 - 28
  • [25] Plasma galactose-deficient IgA1 and C3 and CKD Progression in IgA nephropathy
    Yu, G. -Z.
    Chen, P.
    Zhang, X.
    Shi, S. -F.
    Lv, J. -C.
    Zhang, H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 916 - 916
  • [26] Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy
    Chen, Pei
    Yu, Guizhen
    Zhang, Xue
    Xie, Xinfang
    Wang, Jinwei
    Shi, Sufang
    Liu, Lijun
    Lv, Jicheng
    Zhang, Hong
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (10): : 1458 - 1465
  • [27] Renal cortical complement C3 gene expression in IgA nephropathy
    Montinaro, V
    Gesualdo, L
    Ranieri, E
    Monno, R
    Grandaliano, G
    Schena, FP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 (03): : 415 - 425
  • [28] Aberrant O-glycosylation of IgA1 in IgA nephropathy: Single-cell transcriptome analysis identified a subset of IgA1-producing cells with altered expression of C1GALT1 and MAPK
    Reily, Colin
    Crossman, David K.
    Julian, Bruce A.
    Novak, Jan
    GLYCOBIOLOGY, 2021, 31 (12) : 1714 - 1714
  • [29] Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patients
    Chiu, Yen-Ling
    Lin, Wei-Chou
    Shu, Kai-Hsiang
    Fang, Yi-Wen
    Chang, Fan-Chi
    Chou, Yu-Hsiang
    Wu, Ching-Fang
    Chiang, Wen-Chih
    Lin, Shuei-Liong
    Chen, Yung-Ming
    Wu, Ming-Shiou
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [30] Elevated Plasma α-Defensins (HNP1-3) Levels Correlated with IgA1 Glycosylation and Susceptibility to IgA Nephropathy
    Qi, Yuan-yuan
    Zhou, Xu-jie
    Cheng, Fa-juan
    Zhang, Hong
    DISEASE MARKERS, 2016, 2016